These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
336 related items for PubMed ID: 16291211
1. Human clinical trials of plasmid DNA vaccines. Liu MA, Ulmer JB. Adv Genet; 2005; 55():25-40. PubMed ID: 16291211 [Abstract] [Full Text] [Related]
2. DNA vaccines: successes and limitations in cancer and infectious disease. Lowe DB, Shearer MH, Kennedy RC. J Cell Biochem; 2006 May 15; 98(2):235-42. PubMed ID: 16440328 [Abstract] [Full Text] [Related]
3. From plasmids to protection: a review of DNA vaccines against infectious diseases. Laddy DJ, Weiner DB. Int Rev Immunol; 2006 May 15; 25(3-4):99-123. PubMed ID: 16818367 [Abstract] [Full Text] [Related]
4. Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases. Fuller DH, Loudon P, Schmaljohn C. Methods; 2006 Sep 15; 40(1):86-97. PubMed ID: 16997717 [Abstract] [Full Text] [Related]
5. [Novel vaccines against M. tuberculosis]. Okada M. Kekkaku; 2006 Dec 15; 81(12):745-51. PubMed ID: 17240920 [Abstract] [Full Text] [Related]
6. Optimization and delivery of plasmid DNA for vaccination. Jechlinger W. Expert Rev Vaccines; 2006 Dec 15; 5(6):803-25. PubMed ID: 17184219 [Abstract] [Full Text] [Related]
7. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines. Dietrich G, Spreng S, Favre D, Viret JF, Guzman CA. Curr Opin Mol Ther; 2003 Feb 15; 5(1):10-9. PubMed ID: 12669465 [Abstract] [Full Text] [Related]
8. DNA vaccines: an historical perspective and view to the future. Liu MA. Immunol Rev; 2011 Jan 15; 239(1):62-84. PubMed ID: 21198665 [Abstract] [Full Text] [Related]
10. Current progress of DNA vaccine studies in humans. Lu S, Wang S, Grimes-Serrano JM. Expert Rev Vaccines; 2008 Mar 15; 7(2):175-91. PubMed ID: 18324888 [Abstract] [Full Text] [Related]
11. Vaccination with liposome--DNA complexes elicits enhanced antitumor immunity. U'Ren L, Kedl R, Dow S. Cancer Gene Ther; 2006 Nov 15; 13(11):1033-44. PubMed ID: 16841080 [Abstract] [Full Text] [Related]
12. Chemical adjuvants for plasmid DNA vaccines. Greenland JR, Letvin NL. Vaccine; 2007 May 10; 25(19):3731-41. PubMed ID: 17350735 [Abstract] [Full Text] [Related]
13. Plasmid DNA for pharmaceutical applications. Schleef M, Schmidt T, Flaschel E. Dev Biol (Basel); 2000 May 10; 104():25-31. PubMed ID: 11713820 [Abstract] [Full Text] [Related]
14. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies. Soboll G, Hussey SB, Whalley JM, Allen GP, Koen MT, Santucci N, Fraser DG, Macklin MD, Swain WF, Lunn DP. Vet Immunol Immunopathol; 2006 May 15; 111(1-2):81-95. PubMed ID: 16549215 [Abstract] [Full Text] [Related]
15. Vaccines for lymphomas: idiotype vaccines and beyond. Houot R, Levy R. Blood Rev; 2009 May 15; 23(3):137-42. PubMed ID: 18951668 [Abstract] [Full Text] [Related]
16. DNA vaccines and their application against parasites--promise, limitations and potential solutions. Smooker PM, Rainczuk A, Kennedy N, Spithill TW. Biotechnol Annu Rev; 2004 May 15; 10():189-236. PubMed ID: 15504707 [Abstract] [Full Text] [Related]
17. BHT-3009, a myelin basic protein-encoding plasmid for the treatment of multiple sclerosis. Correale J, Fiol M. Curr Opin Mol Ther; 2009 Aug 15; 11(4):463-70. PubMed ID: 19649992 [Abstract] [Full Text] [Related]
18. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice. Zhang X, Yu C, Zhao J, Fu L, Yi S, Liu S, Yu T, Chen W. J Gene Med; 2007 Aug 15; 9(8):715-26. PubMed ID: 17595048 [Abstract] [Full Text] [Related]
19. [New advances in clinical trials of cancer vaccines]. Peng F, Wei YQ. Ai Zheng; 2006 Aug 15; 25(8):1059-62. PubMed ID: 16965694 [Abstract] [Full Text] [Related]